The hydrocephalus shunt market is valued at US$ 546.09 million in 2024 and is projected to reach US$ 692.25 million by 2034, exhibiting a sluggish CAGR of 2.40% over the forecast period.
Key Market Drivers:
The hydrocephalus shunt market generated an estimated revenue of US$ 476.71 million in 2018. Over the span of four years, the market grew at a pace of a 2.71% CAGR and added revenue of US$ 53.99 million. Several reasons can be attributed to this growth:
Attributes | Key Statistics |
---|---|
Expected Base Year Value (2024) | US$ 546.09 million |
Anticipated Forecast Value (2034) | US$ 692.25 million |
Estimated Growth (2024 to 2034) | 2.40% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market is anticipated to surpass a global valuation of US$ 692.25 million by the year 2034, with a growth rate of 2.40% CAGR. While the market is expected to experience remarkable growth, several restraining factors could adversely affect its development:
A comprehensive study has been conducted on the global healthcare sector, and it has been parallelly analyzed with two markets that have the potential to pose rigorous competition to the hydrocephalus shunt market: the cell culture incubator market and the Stem Cell Therapies Market. The growth rates and the current market valuation have been mentioned in the table below.
The growth factors and critical challenges in the respective markets have also been discussed below. Based on these numbers, the market for stem cell therapy is anticipated to overpower the other two in the coming future.
Hydrocephalus Shunt Market:
Attributes | Hydrocephalus Shunt Market |
---|---|
CAGR (2024 to 2034) | 2.40% |
Market Value (2024) | US$ 546.09 million |
Growth Factor | Growing awareness among healthcare professionals and patients about the benefits of shunt treatment |
Challenges | Complications associated with shunt implantation, such as infections and blockages |
Cell Culture Incubator Market:
Attributes | Cell Culture Incubator Market |
---|---|
CAGR (2024 to 2034) | 6.40% |
Market Value (2024) | US$ 2,463.69 million |
Growth Factor | Growing prevalence of chronic diseases driving the need for personalized medicine and cell-based therapies |
Challenges | Regulatory complexities and ethical considerations surrounding the use of cell-based products |
Stem Cell Therapies Market:
Attributes | Stem Cell Therapies Market |
---|---|
CAGR (2024 to 2034) | 16.70% |
Market Value (2024) | US$ 254.67 million |
Growth Factor | Growing investments in stem cell research and development by biotechnology and pharmaceutical companies |
Challenges | The high cost of stem cell therapies and limited understanding of long-term safety are limiting accessibility for some patients |
Depending on the products, the hydrocephalus shunt market is bifurcated into hydrocephalus valves and hydrocephalus catheters. The hydrocephalus valves segment is anticipated to hold a market value of 85.24%.
Attributes | Details |
---|---|
Product | Hydrocephalus Valves |
Market Share in 2024 | 85.24% |
The hydrocephalus shunt market is categorized by procedures into ventriculoperitoneal, ventriculoatrial, lumboperitoneal, and ventriculopleural. The ventriculoperitoneal sector dominates the market with a share of 93.45%.
Attributes | Details |
---|---|
Procedure | Ventriculoperitoneal |
Market Share in 2024 | 93.45% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section provides an analysis of the hydrocephalus shunt market by country, including India, China, and the United Kingdom. The table presents the CAGR for each country, indicating the expected growth of the market in that country through 2034.
Countries | Forecasted CAGR (2024 to 2034) |
---|---|
India | 3.80% |
China | 3.50% |
The United Kingdom | 2.20% |
India leads the hydrocephalus shunt market. Over the next ten years, the demand for hydrocephalus shunts in India is projected to rise at a 3.80% CAGR.
China is also one of the leading countries in the hydrocephalus shunt industry. The China hydrocephalus shunt market is anticipated to retain its supremacy by progressing at a compound annual growth rate of 3.50% until 2034.
The United Kingdom dominates the hydrocephalus shunt industry in Europe. The United Kingdom hydrocephalus shunt market is anticipated to retain its dominance by progressing at a CAGR of 2.20% through 2034.
The market for hydrocephalus shunts is populated with international and domestic players that cater to a broad spectrum of healthcare facilities such as hospitals, specialty clinics, ambulatory surgical centers, rehabilitation centers, etc.
Some of the prominent companies in the hydrocephalus shunt market are Medtronic plc, Johnson & Johnson Services, Inc., B. Braun Melsungen AG, Sophysa SA, Integra LifeSciences Corporation, and Spiegelberg GmbH & Co. KG. These companies have established a strong foothold in the market due to their prolonged presence and widespread reach.
Recent Developments:
The current worth of the hydrocephalus shunt market is US$ 546.09 million as of 2024.
The market is expected to reach US$ 692.25 million by 2034.
The market is forecasted to develop at a CAGR of 2.40% from 2024 to 2034.
Medtronic plc, Johnson & Johnson Services, Inc., B. Braun Melsungen AG, Sophysa SA, Integra LifeSciences Corporation, etc., are some of the key players in the hydrocephalus shunt market.
The market valuation in 2023 was US$ 530.70 million.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2024 to 2034 5.3.1. Hydrocephalus Valves 5.3.1.1. Fixed Pressure Valves 5.3.1.2. Adjustable Pressure Valves 5.3.2. Hydrocephalus Catheters 5.3.2.1. Standard Catheters 5.3.2.2. Antimicrobial Catheters 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Procedure Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Procedure Type, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Procedure Type, 2024 to 2034 6.3.1. Ventriculoperitoneal 6.3.2. Ventriculoatrial 6.3.3. Lumboperitoneal 6.3.4. Ventriculopleural 6.4. Y-o-Y Growth Trend Analysis By Procedure Type, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Procedure Type, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Age Group 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Age Group, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Age Group, 2024 to 2034 7.3.1. Pediatric 7.3.2. Adults 7.4. Y-o-Y Growth Trend Analysis By Age Group, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Age Group, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Procedure Type 9.2.4. By Age Group 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Procedure Type 9.3.4. By Age Group 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Procedure Type 10.2.4. By Age Group 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Procedure Type 10.3.4. By Age Group 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Procedure Type 11.2.4. By Age Group 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Procedure Type 11.3.4. By Age Group 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Procedure Type 12.2.4. By Age Group 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Procedure Type 12.3.4. By Age Group 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product Type 13.2.3. By Procedure Type 13.2.4. By Age Group 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Procedure Type 13.3.4. By Age Group 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product Type 14.2.3. By Procedure Type 14.2.4. By Age Group 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Procedure Type 14.3.4. By Age Group 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product Type 15.2.3. By Procedure Type 15.2.4. By Age Group 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Procedure Type 15.3.4. By Age Group 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Product Type 16.1.2.2. By Procedure Type 16.1.2.3. By Age Group 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Product Type 16.2.2.2. By Procedure Type 16.2.2.3. By Age Group 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Product Type 16.3.2.2. By Procedure Type 16.3.2.3. By Age Group 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Product Type 16.4.2.2. By Procedure Type 16.4.2.3. By Age Group 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Product Type 16.5.2.2. By Procedure Type 16.5.2.3. By Age Group 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Product Type 16.6.2.2. By Procedure Type 16.6.2.3. By Age Group 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Product Type 16.7.2.2. By Procedure Type 16.7.2.3. By Age Group 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Product Type 16.8.2.2. By Procedure Type 16.8.2.3. By Age Group 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Product Type 16.9.2.2. By Procedure Type 16.9.2.3. By Age Group 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Product Type 16.10.2.2. By Procedure Type 16.10.2.3. By Age Group 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Product Type 16.11.2.2. By Procedure Type 16.11.2.3. By Age Group 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Product Type 16.12.2.2. By Procedure Type 16.12.2.3. By Age Group 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Product Type 16.13.2.2. By Procedure Type 16.13.2.3. By Age Group 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Product Type 16.14.2.2. By Procedure Type 16.14.2.3. By Age Group 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Product Type 16.15.2.2. By Procedure Type 16.15.2.3. By Age Group 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Product Type 16.16.2.2. By Procedure Type 16.16.2.3. By Age Group 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Product Type 16.17.2.2. By Procedure Type 16.17.2.3. By Age Group 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Product Type 16.18.2.2. By Procedure Type 16.18.2.3. By Age Group 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Product Type 16.19.2.2. By Procedure Type 16.19.2.3. By Age Group 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Product Type 16.20.2.2. By Procedure Type 16.20.2.3. By Age Group 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Product Type 16.21.2.2. By Procedure Type 16.21.2.3. By Age Group 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Product Type 16.22.2.2. By Procedure Type 16.22.2.3. By Age Group 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Product Type 16.23.2.2. By Procedure Type 16.23.2.3. By Age Group 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Procedure Type 17.3.4. By Age Group 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Christoph Miethke GmbH & Co. KG 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Medtronic PLC 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Sophysa 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Tokibo Co. Ltd 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Spiegelberg GmbH & Co. KG 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. B. Braun Melsungen AG 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Integra LifeSciences Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Johnson & Johnson 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Desu Medical 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Natus Medical Incorporated 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports